Genetic variation in telomeric repeat binding factors 1 and 2 in aplastic anemia.

[1]  Stephen J Chanock,et al.  Genetic variation, nucleotide diversity, and linkage disequilibrium in seven telomere stability genes suggest that these genes may be under constraint , 2005, Human mutation.

[2]  S. Chanock,et al.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. , 2005, The New England journal of medicine.

[3]  T. Vulliamy,et al.  Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC , 2004, Nature Genetics.

[4]  Peter Donnelly,et al.  A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.

[5]  S. Chanock,et al.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome. , 2003, Blood.

[6]  N. Laird,et al.  Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous , 2003, Human Heredity.

[7]  Steven Henikoff,et al.  SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..

[8]  W. Hahn,et al.  Erosion of the telomeric single-strand overhang at replicative senescence , 2003, Nature Genetics.

[9]  R. DePinho,et al.  Connecting chromosomes, crisis, and cancer. , 2002, Science.

[10]  N. Young.  Acquired Aplastic Anemia , 2002, Annals of Internal Medicine.

[11]  A. Smogorzewska,et al.  Senescence Induced by Altered Telomere State, Not Telomere Loss , 2002, Science.

[12]  P. Donnelly,et al.  A new statistical method for haplotype reconstruction from population data. , 2001, American journal of human genetics.

[13]  G. Starace,et al.  The length of telomeric G-rich strand 3'-overhang measured by oligonucleotide ligation assay. , 2001, Nucleic acids research.

[14]  J. Shay,et al.  Telomerase and cancer. , 2001, Human molecular genetics.

[15]  K. Devriendt,et al.  Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis , 2001, Human Genetics.

[16]  Warren C. Lathe,et al.  Prediction of deleterious human alleles. , 2001, Human molecular genetics.

[17]  S. Salzberg,et al.  GeneSplicer: a new computational method for splice site prediction. , 2001, Nucleic acids research.

[18]  D. Nickerson,et al.  Variation is the spice of life , 2001, Nature Genetics.

[19]  T. Brümmendorf,et al.  Telomere length in leukocyte subpopulations of patients with aplastic anemia. , 2001, Blood.

[20]  B. van Steensel,et al.  Control of Human Telomere Length by TRF1 and TRF2 , 2000, Molecular and Cellular Biology.

[21]  A. Poustka,et al.  X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. , 1999, American journal of human genetics.

[22]  J. Tooze,et al.  Progressive Telomere Shortening in Aplastic Anemia , 1998 .

[23]  Bas van Steensel,et al.  TRF2 Protects Human Telomeres from End-to-End Fusions , 1998, Cell.

[24]  D. Broccoli,et al.  Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2 , 1997, Nature Genetics.

[25]  Bas van Steensel,et al.  Control of telomere length by the human telomeric protein TRF1 , 1997, Nature.

[26]  David Haussler,et al.  Improved splice site detection in Genie , 1997, RECOMB '97.

[27]  R. Grantham.  Amino Acid Difference Formula to Help Explain Protein Evolution , 1974, Science.

[28]  Brian Staats,et al.  SNP500Cancer: a public resource for sequence validation and assay development for genetic variation in candidate genes , 2004, Nucleic Acids Res..

[29]  T. Lange,et al.  TRF1, a mammalian telomeric protein. , 1997, Trends in genetics : TIG.

[30]  H. Heimpel.  Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study. , 1987, Blood.